AP-III-a4 compound,
ENOblock,
N-(2-(2-(2-aminoethoxy)ethoxy)ethyl)-4-((4-(cyclohexylmethyl)amino-6-((4-fluorophenyl)methyl)amino-1,3,5-triazin-2-yl)amino)benzeneacetamide,
AP-III-a4,
1177827-73-4,
ENOblock,
CHEMBL3335790,
AP-III-a4 (ENOblock),
ap-3-a4-enoblock,
ENO block(AP-III-a4),
SCHEMBL14930852,
AOB6856,
EX-A364,
BCP08997,
BDBM50103566,
MFCD28009373,
ZINC98043807,
AKOS027338717,
CS-2330,
YTC_000912,
YTC_000980,
NCGC00371157-01,
HY-15858,
QC-11393,
A11840,
N-(2-(2-(2-Aminoethoxy)ethoxy)ethyl)-2-(4-((4-((cyclohexylmethyl)amino)-6-((4-fluorobenzyl)amino)-1,3,5-triazin-2-yl)amino)phenyl)acetamide,
N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-2-[4-({4-[(cyclohexylmethyl)amino]-6-{[(4-fluorophenyl)methyl]amino}-1,3,5-triazin-2-yl}amino)phenyl]acetamide,
AP-III-a4 HCl,
ACN-039846,
AP-III-a4 (ENO block) (HCl salt),
Benzeneacetamide, N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-4-[[4-[(cyclohexylmethyl)amino]-6-[[(4-fluorophenyl)methyl]amino]-1,3,5-triazin-2-yl]amino]-,